Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 28:21:100198.
doi: 10.1016/j.jctube.2020.100198. eCollection 2020 Dec.

Validity of a CB-NAAT assay in diagnosing tuberculosis in comparison to culture: A study from an urban area of South India

Aishwarya Raj  1 , Shrikala Baliga  2   3 , M Suchitra Shenoy  2   3 , B Dhanashree  2   3 , P Prasanna Mithra  4 , Smitha K Nambiar  2 , Leesha Sharon  2
Affiliations

Validity of a CB-NAAT assay in diagnosing tuberculosis in comparison to culture: A study from an urban area of South India

Aishwarya Raj et al. J Clin Tuberc Other Mycobact Dis. .

Erratum in

  • Erratum regarding previously published articles.
    [No authors listed] [No authors listed] J Clin Tuberc Other Mycobact Dis. 2021 May 6;24:100242. doi: 10.1016/j.jctube.2021.100242. eCollection 2021 Aug. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34095548 Free PMC article.

Abstract

•CB-NAAT performance compared in 831 suspected pulmonary and extrapulmonary suspected cases.•The conventional stained smear and CB-NAAT results were compared to the MGIT culture.•Sensitivity and specificity of CB-NAAT was 84.43% and 94.93%.•The rapid results from CB-NAAT confirms its use in the tuberculosis diagnostic algorithm.•The benefits of disease diagnosis and prevention outweighs the price tag of the CB-NAAT tests.•This is more so for the resource poor countries where the burden of the disease is high.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Distribution of pulmonary samples.
Fig. 2
Fig. 2
Distribution of extrapulmonary samples.
See this image and copyright information in PMC

References

    1. Mcnerney R., Clark T.G., Campino S., Rodrigues C., Dolinger D., Smith L. Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action. Int J Infect Dis. 2016;56:130–135. - PubMed
    1. Innovation C. Cepheid Innovation; Sunnyvale (CA): 2012. GeneXpert® Xpert® MTB/RIF; pp. 1–24.
    1. Central TB Division. Manual for sputum smear fluorescence microscopy. New Delhi: Central TB Division; 1–16 p.
    1. Siddiqi S., Rüsch-Gerdes S. Foundation for Innovative Diagnostics; Geneva (CH): 2006. MGITTM procedure manual; pp. 1–89.
    1. World Health Organization. Global tuberculosis report 2017 [Internet]; 2017. Available from: http://www.who.int/tb/publications/global_report/en/.

LinkOut - more resources